Brendan Ottemann

Brendan Ottemann

University of Kansas

H-index: 7

North America-United States

About Brendan Ottemann

Brendan Ottemann, With an exceptional h-index of 7 and a recent h-index of 7 (since 2020), a distinguished researcher at University of Kansas, specializes in the field of Molecular biology, pharmacology, nanoparticles, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs

Development of improved tumor-residualizing, GRPR-targeted agents: Preclinical comparison of an endolysosomal trapping approach in agonistic and antagonistic constructs

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues

Brendan Ottemann Information

University

Position

Post-Doctoral Scientist Medical Center

Citations(all)

263

Citations(since 2020)

228

Cited By

129

hIndex(all)

7

hIndex(since 2020)

7

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Brendan Ottemann Skills & Research Interests

Molecular biology

pharmacology

nanoparticles

cancer

Top articles of Brendan Ottemann

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs

Nanotheranostics

2021

Development of improved tumor-residualizing, GRPR-targeted agents: Preclinical comparison of an endolysosomal trapping approach in agonistic and antagonistic constructs

Journal of Nuclear Medicine

2020/3/1

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues

Theranostics

2020

See List of Professors in Brendan Ottemann University(University of Kansas)